
Spiriva Handihaler Coupons & Discount Card - Compare Prices Near You
tiotropium
My prescription
Edit
18MCG, Tiotropium (30 Capsules)
Select pharmacy

Walgreens
$141.78
COUPON PRICE
Rite Aid
$385.59
COUPON PRICE
Walmart
$421.65
COUPON PRICESpiriva Handihaler savings card
Show this card to your pharmacist
Walgreens
$141.78
BIN
ID
PCN
GRP
019876
LH4A11C193
CHIPPO
LHX
Powered by
More prescriptions for COPD
More prescriptions for COPD
Spiriva Handihaler dosage forms
Dosage | Quantity | Price from | Per unit |
---|---|---|---|
18MCG | 30 Capsules | $141.78 | $4.73 |
Spiriva Handihaler Side Effects
You might experience mild side effects like dry mouth, constipation, or dizziness. Usually, these are not serious, but if they persist or worsen, consult with your healthcare provider. Most people tolerate the medication well without major issues.
In rare instances, this medication can cause a severe and sudden worsening of breathing problems. If this happens, use your quick-relief inhaler and seek immediate medical attention. Also, inform your healthcare provider if you experience serious side effects such as difficult or painful urination, or a rapid heartbeat.
Seek urgent medical help if you encounter any very serious side effects. These include eye pain, swelling, redness, changes in vision like seeing halos around lights, or blurred vision. An allergic reaction to this medication is rare, but if you notice a rash, itching, swelling (especially of the face, tongue, or throat), severe dizziness, or trouble breathing, get emergency help right away.
This summary does not list all possible side effects. If you notice other unusual symptoms, contact your healthcare provider for guidance.
Which is better, Spiriva HandiHaler or Respimat?
The choice between Spiriva HandiHaler and Respimat depends on the patient's specific needs and preferences. Both deliver the same medication, tiotropium, but in different forms. The HandiHaler is a dry powder inhaler, while the Respimat is a soft mist inhaler. Some patients may find the Respimat easier to use, especially if they have difficulty with the inhalation technique required for dry powder inhalers. It is important for patients to consult with their healthcare provider to determine which device is more suitable for their condition and ability to use the inhaler correctly.
What's the difference between Spiriva Respimat and Spiriva HandiHaler?
Spiriva Respimat and Spiriva HandiHaler are both used to manage chronic obstructive pulmonary disease (COPD), but they differ in their delivery methods. Spiriva Respimat is an inhaler that delivers a fine mist of medication, which may be easier for some patients to inhale deeply into the lungs. Spiriva HandiHaler, on the other hand, uses a dry powder inhalation system where the patient inhales the medication from a capsule placed in the device. The choice between the two may depend on patient preference, ease of use, and specific medical advice from a healthcare provider.
How much does a 30 day supply of Spiriva cost?
The cost of a 30-day supply of Spiriva can vary depending on factors such as the pharmacy, location, and whether the patient has insurance coverage. Without insurance, the price can range from approximately $400 to $500. Patients are encouraged to check with their local pharmacy for the most accurate pricing and to inquire about any available discounts or patient assistance programs.
What is Spiriva HandiHaler used for?
Spiriva HandiHaler is used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD), which includes conditions such as chronic bronchitis and emphysema. It helps to relax the muscles around the airways, making it easier to breathe and reducing symptoms like wheezing and shortness of breath.
Does Spiriva affect sleep?
Spiriva is not commonly associated with affecting sleep. However, some individuals may experience side effects that could potentially impact sleep, such as dry mouth or throat irritation. If there are concerns about sleep disturbances while taking Spiriva, it is advisable to consult a healthcare provider for further evaluation and guidance.